Cited by 33Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research

Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors

Open access
Liu, Ling, Aboud, Orwa, Jones, Richard A, Mrak, Robert E, Griffin, W Sue T, Barger, Steven W·2011·Journal of Neuroinflammation

Abstract

Background: We have previously outlined functional interactions, including feedback cycles, between several of the gene products implicated in the pathogenesis of Alzheimer's disease. A number of Alzheimer-related stressors induce neuronal expression of apolipoprotein E (ApoE), β-amyloid precursor protein (βAPP), and fragments of the latter such as amyloid β-peptide (Aβ) and secreted APP (sAPP). These stressors include interleukin-1 (IL-1)-mediated neuroinflammation and glutamate-mediated excitotoxicity. Such circumstances are especially powerful when they transpire in the context of an APOE ε4 allele. Methods: Semi-quantitative immunofluorescence imaging was used to analyze rat brains implanted with IL-1β slow-release pellets, sham pellets, or no pellets. Primary neuronal or NT2 cell cultures were treated with IL-1β, glutamate, Aβ, or sAPP; relative levels of ApoE mRNA and protein were measured by RT-PCR, qRT-PCR, and western immunoblot analysis. Cultures were also treated with inhibitors of multi-lineage kinases--in particular MAPK-p38 (SB203580), ERK (U0126), or JNK (SP600125)--prior to exposure of cultures to IL-1β, Aβ, sAPP, or glutamate. Results: Immunofluorescence of tissue sections from pellet-implanted rats showed that IL-1β induces expression of βAPP, IL-1α, and ApoE; the latter was confirmed by western blot analysis. These protein changes were mirrored by increases in their mRNAs, as well as in those encoding IL-1β, IL-1β-converting enzyme (ICE), and tumor necrosis factor (TNF). IL-1β also increased ApoE expression in neuronal cultures. It stimulated release of sAPP and glutamate in these cultures too, and both of these agents--as well as Aβ--stimulated ApoE expression themselves, suggesting that they may contribute to the effect of IL-1β on ApoE levels. Inhibitors of MAPK-p38, ERK, and JNK inhibited ApoE induction by all these agents except glutamate, which was sensitive only to inhibitors of ERK and JNK. Conclusion: Conditions of glial activation and hyperexcitation can elevate proinflammatory cytokines, ApoE, glutamate, βAPP, and its secreted fragments. Because each of these factors promotes glial activation and neuronal hyperexcitation, these relationships have the potential to sustain self-propagating neurodegenerative cycles that could culminate in a progressive neurodegenerative disorder such as Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-8-175

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 66

  1. Blackman JA Worley G Strittmatter WJ Apolipoprotein E and brain injury: implications for children Dev Med Child Neurol 2005 47 64 70 15686292
  2. D'Arcangelo G Apoer2: a reelin receptor to remember Neuron 2005 47 471 473 10.1016/j.neuron.2005.08.001 16102527 · DOI · Paper page
  3. D'Arcangelo G Homayouni R Keshvara L Rice DS Sheldon M Curran T Reelin is a ligand for lipoprotein receptors Neuron 1999 24 471 479 10.1016/S0896-6273(00)80860-0 10571240 · DOI · Paper page
  4. Strittmatter WJ Bova Hill C Molecular biology of apolipoprotein E Curr Opin Lipidol 2002 13 119 123 10.1097/00041433-200204000-00002 11891413 · DOI
  5. Strittmatter WJ Saunders AM Goedert M Weisgraber KH Dong LM Jakes R Huang DY Pericak-Vance M Schmechel D Roses AD Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease Proc Natl Acad Sci USA 1994 91 11183 11186 10.1073/pnas.91.23.11183 7972031 PMC45191 · DOI · Paper page
  6. Bu G Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Nat Rev Neurosci 2009 PMC2908393 19339974
  7. Boschert U Merlo-Pich E Higgins G Roses AD Catsicas S Apolipoprotein E expression by neurons surviving excitotoxic stress Neurobiol Dis 1999 6 508 514 10.1006/nbdi.1999.0251 10600406 · DOI
  8. Xu Q Bernardo A Walker D Kanegawa T Mahley RW Huang Y Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus J Neurosci 2006 26 4985 4994 10.1523/JNEUROSCI.5476-05.2006 16687490 PMC6674234 · DOI · Paper page
  9. Du Y Dodel RC Eastwood BJ Bales KR Gao F Lohmuller F Muller U Kurz A Zimmer R Evans RM Association of an interleukin 1 alpha polymorphism with Alzheimer's disease Neurology 2000 55 480 483 10953177
  10. Grimaldi LM Casadei VM Ferri C Veglia F Licastro F Annoni G Biunno I De Bellis G Sorbi S Mariani C Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism Ann Neurol 2000 47 361 365 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N 10716256 · DOI
  11. Nicoll JA Mrak RE Graham DI Stewart J Wilcock G MacGowan S Esiri MM Murray LS Dewar D Love S Association of interleukin-1 gene polymorphisms with Alzheimer's disease Ann Neurol 2000 47 365 368 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G 10716257 PMC3833599 · DOI
  12. Rebeck GW Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease Neurosci Lett 2000 293 75 77 10.1016/S0304-3940(00)01487-7 11065142 · DOI
  13. Griffin WS Sheng JG Gentleman SM Graham DI Mrak RE Roberts GW Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression Neurosci Lett 1994 176 133 136 10.1016/0304-3940(94)90066-3 7830934 PMC3833643 · DOI
  14. Stanley LC Mrak RE Woody RC Perrot LJ Zhang S Marshak DR Nelson SJ Griffin WS Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease J Neuropathol Exp Neurol 1994 53 231 238 10.1097/00005072-199405000-00003 8176406 · DOI
  15. Sheng JG Boop FA Mrak RE Griffin WS Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity J Neurochem 1994 63 1872 1879 7931344 PMC3833617
  16. Griffin WS Yeralan O Sheng JG Boop FA Mrak RE Rovnaghi CR Burnett BA Feoktistova A Van Eldik LJ Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy J Neurochem 1995 65 228 233 7790864 PMC3833622
  17. Vezzani A Balosso S Ravizza T The role of cytokines in the pathophysiology of epilepsy Brain Behav Immun 2008 22 797 803 10.1016/j.bbi.2008.03.009 18495419 · DOI
  18. Griffin WS Stanley LC Ling C White L MacLeod V Perrot LJ White CL Araoz C Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc Natl Acad Sci USA 1989 86 7611 7615 10.1073/pnas.86.19.7611 2529544 PMC298116 · DOI · Paper page
  19. Sheng JG Mrak RE Griffin WS Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain Acta Neuropathol (Berl) 1998 95 229 234 10.1007/s004010050792 9542587 · DOI
  20. Gee JR Ding Q Keller JN Age-related alterations of Apolipoprotein E and interleukin-1beta in the aging brain Biogerontology 2006 7 69 79 10.1007/s10522-005-6039-9 16802110 · DOI
  21. Esiri MM Biddolph SC Morris CS Prevalence of Alzheimer plaques in AIDS J Neurol Neurosurg Psychiatry 1998 65 29 33 10.1136/jnnp.65.1.29 9667557 PMC2170157 · DOI
  22. Graham DI Gentleman SM Nicoll JA Royston MC McKenzie JE Roberts GW Griffin WS Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease Acta Neurochir Suppl 1996 66 96 102 8780805
  23. Gouras GK Relkin NR Sweeney D Munoz DG Mackenzie IR Gandy S Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques Ann Neurol 1997 41 402 404 10.1002/ana.410410317 9066363 · DOI
  24. Teasdale GM Murray GD Nicoll JA The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study Brain 2005 128 2556 2561 10.1093/brain/awh595 16033781 · DOI
  25. Corder EH Robertson K Lannfelt L Bogdanovic N Eggertsen G Wilkins J Hall C HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy Nat Med 1998 4 1182 1184 10.1038/2677 9771753 · DOI
  26. Prasher VP Farrer MJ Kessling AM Fisher EM West RJ Barber PC Butler AC Molecular mapping of Alzheimer-type dementia in Down's syndrome Ann Neurol 1998 43 380 383 10.1002/ana.410430316 9506555 · DOI · Paper page
  27. Sheng JG Ito K Skinner RD Mrak RE Rovnaghi CR Van Eldik LJ Griffin WS In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis Neurobiol Aging 1996 17 761 766 10.1016/0197-4580(96)00104-2 8892349 PMC3886636 · DOI · Paper page
  28. Barger SW Harmon AD Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E Nature 1997 388 878 881 10.1038/42257 9278049 · DOI · Paper page
  29. Sheng JG Mrak RE Griffin WS Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression Neuropathol Appl Neurobiol 1996 22 334 341 10.1111/j.1365-2990.1996.tb01112.x 8875468 · DOI
  30. Bales KR Verina T Cummins DJ Du Y Dodel RC Saura J Fishman CE DeLong CA Piccardo P Petegnief V Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease Proc Natl Acad Sci USA 1999 96 15233 15238 10.1073/pnas.96.26.15233 10611368 PMC24803 · DOI · Paper page
  31. Griffin WS Liu L Li Y Mrak RE Barger SW Interleukin-1 mediates Alzheimer and Lewy body pathologies J Neuroinflammation 2006 3 5 10.1186/1742-2094-3-5 16542445 PMC1435743 · DOI
  32. Barger SW DeWall KM Liu L Mrak RE Griffin WS Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies J Neuropathol Exp Neurol 2008 67 773 783 10.1097/NEN.0b013e318180ec47 18648325 PMC3334532 · DOI
  33. Senechal Y Kelly PH Dev KK Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning Behav Brain Res 2008 186 126 132 10.1016/j.bbr.2007.08.003 17884188 · DOI
  34. Dawson GR Seabrook GR Zheng H Smith DW Graham S O'Dowd G Bowery BJ Boyce S Trumbauer ME Chen HY Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein Neuroscience 1999 90 1 13 10.1016/S0306-4522(98)00410-2 10188929 · DOI
  35. Laskowitz DT Matthew WD Bennett ER Schmechel D Herbstreith MH Goel S McMillian MK Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production Neuroreport 1998 9 615 618 10.1097/00001756-199803090-00010 9559926 · DOI
  36. Lynch JR Morgan D Mance J Matthew WD Laskowitz DT Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response J Neuroimmunol 2001 114 107 113 10.1016/S0165-5728(00)00459-8 11240021 · DOI
  37. Koistinaho M Kettunen MI Holtzman DM Kauppinen RA Higgins LS Koistinaho J Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility Stroke 2002 33 1905 1910 10.1161/01.STR.0000020124.61998.BC 12105373 · DOI
  38. Li Y Liu L Kang J Sheng JG Barger SW Mrak RE Griffin WS Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression J Neurosci 2000 20 149 155 10627591 PMC6774108
  39. Li Y Wang J Sheng JG Liu L Barger SW Jones RA Van Eldik LJ Mrak RE Griffin WS S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures J Neurochem 1998 71 1421 1428 9751173
  40. Wu SZ Bodles AM Porter MM Griffin WS Basile AS Barger SW Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide J Neuroinflammation 2004 1 2 10.1186/1742-2094-1-2 15285800 PMC483052 · DOI
  41. Li Y Liu L Barger SW Mrak RE Griffin WS Vitamin E suppression of microglial activation is neuroprotective J Neurosci Res 2001 66 163 170 10.1002/jnr.1208 11592111 PMC3903400 · DOI
  42. Buxbaum JD Oishi M Chen HI Pinkas-Kramarski R Jaffe EA Gandy SE Greengard P Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor Proc Natl Acad Sci USA 1992 89 10075 10078 10.1073/pnas.89.21.10075 1359534 PMC50280 · DOI
  43. Sheng JG Jones RA Zhou XQ McGinness JM Van Eldik LJ Mrak RE Griffin WS Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation Neurochem Int 2001 39 341 348 10.1016/S0197-0186(01)00041-9 11578769 PMC3833633 · DOI · Paper page
  44. Griffin WS Sheng JG Royston MC Gentleman SM McKenzie JE Graham DI Roberts GW Mrak RE Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression Brain Pathol 1998 8 65 72 9458167 PMC8098321
  45. Mrak RE Sheng JG Griffin WS Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease J Neuropathol Exp Neurol 1996 55 273 279 10.1097/00005072-199603000-00002 8786385 PMC3833601 · DOI
  46. Meda L Baron P Prat E Scarpini E Scarlato G Cassatella MA Rossi F Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35] J Neuroimmunol 1999 93 45 52 10.1016/S0165-5728(98)00188-X 10378868 · DOI
  47. Barger SW Mattson MP Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein J Neurochem 1997 69 60 67 9202294
  48. Wu S Basile AS Barger SW Induction of serine racemase expression and D-serine release from microglia by secreted amyloid precursor protein (sAPP) Curr Alzheimer Res 2007 4 243 251 17627481
  49. Schmechel DE Saunders AM Strittmatter WJ Crain BJ Hulette CM Joo SH Pericak-Vance MA Goldgaber D Roses AD Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc Natl Acad Sci USA 1993 90 9649 9653 10.1073/pnas.90.20.9649 8415756 PMC47627 · DOI · Paper page
  50. Wisniewski T Castano EM Golabek A Vogel T Frangione B Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro Am J Pathol 1994 145 1030 1035 7977635 PMC1887417
  51. Horsburgh K Fitzpatrick M Nilsen M Nicoll JA Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat Brain Res 1997 763 103 110 10.1016/S0006-8993(97)00411-3 9272834 · DOI
  52. Kay A Petzold A Kerr M Keir G Thompson E Nicoll J Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage Stroke 2003 34 e240 243 10.1161/01.STR.0000100157.88508.2F 14605321 · DOI
  53. Lambert JC Perez-Tur J Dupire MJ Galasko D Mann D Amouyel P Hardy J Delacourte A Chartier-Harlin MC Distortion of allelic expression of apolipoprotein E in Alzheimer's disease Hum Mol Genet 1997 6 2151 2154 10.1093/hmg/6.12.2151 9328480 · DOI
  54. Hesse C Larsson H Fredman P Minthon L Andreasen N Davidsson P Blennow K Measurement of apolipoprotein E (apoE) in cerebrospinal fluid Neurochem Res 2000 25 511 517 10.1023/A:1007516210548 10823584 · DOI
  55. Fukumoto H Ingelsson M Garevik N Wahlund LO Nukina N Yaguchi Y Shibata M Hyman BT Rebeck GW Irizarry MC APOE epsilon 3/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis Exp Neurol 2003 183 249 253 10.1016/S0014-4886(03)00088-8 12957508 · DOI · Paper page
  56. Bray NJ Jehu L Moskvina V Buxbaum JD Dracheva S Haroutunian V Williams J Buckland PR Owen MJ O'Donovan MC Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes Hum Mol Genet 2004 13 2885 2892 10.1093/hmg/ddh299 15385439 · DOI · Paper page
  57. Darreh-Shori T Modiri N Blennow K Baza S Kamil C Ahmed H Andreasen N Nordberg A The apolipoprotein E varepsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase Neurobiol Aging 2009 19713000
  58. Beffert U Cohn JS Petit-Turcotte C Tremblay M Aumont N Ramassamy C Davignon J Poirier J Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent Brain Res 1999 843 87 94 10.1016/S0006-8993(99)01894-6 10528114 · DOI · Paper page
  59. Bertrand P Poirier J Oda T Finch CE Pasinetti GM Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease Brain Res Mol Brain Res 1995 33 174 178 8774959
  60. Guo L LaDu MJ Van Eldik LJ A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity J Mol Neurosci 2004 23 205 212 10.1385/JMN:23:3:205 15181248 · DOI · Paper page
  61. Colton CA Brown CM Cook D Needham LK Xu Q Czapiga M Saunders AM Schmechel DE Rasheed K Vitek MP APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress Neurobiol Aging 2002 23 777 785 10.1016/S0197-4580(02)00016-7 12392781 · DOI
  62. Ezra Y Oron L Moskovich L Roses AD Beni SM Shohami E Michaelson DM Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury Neuroscience 2003 121 315 325 10.1016/S0306-4522(03)00436-6 14521991 · DOI
  63. Hoe HS Harris DC Rebeck GW Multiple pathways of apolipoprotein E signaling in primary neurons J Neurochem 2005 93 145 155 10.1111/j.1471-4159.2004.03007.x 15773914 · DOI · Paper page
  64. Ohkubo N Mitsuda N Tamatani M Yamaguchi A Lee YD Ogihara T Vitek MP Tohyama M Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway J Biol Chem 2001 276 3046 3053 10.1074/jbc.M005070200 11042199 · DOI
  65. Soriano FX Martel MA Papadia S Vaslin A Baxter P Rickman C Forder J Tymianski M Duncan R Aarts M Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand J Neurosci 2008 28 10696 10710 10.1523/JNEUROSCI.1207-08.2008 18923045 PMC2602846 · DOI
  66. Xu J Kurup P Zhang Y Goebel-Goody SM Wu PH Hawasli AH Baum ML Bibb JA Lombroso PJ Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP J Neurosci 2009 29 9330 9343 10.1523/JNEUROSCI.2212-09.2009 19625523 PMC2737362 · DOI

Cited by

Sorted by citations

Authors
Liu, L., Aboud, O., Jones, R. A., Mrak, R. E., Griffin, W. S. T., & Barger, S. W.
Affiliations
  • University of Arkansas for Medical Sciences (US)
  • University of Toledo (US)
  • Central Arkansas Veterans Healthcare System (US)
Corresponding author
Griffin, W Sue T
Venue
Journal of Neuroinflammation
Published
2011-12
Volume
8
Issue
1
Pages
175-175
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2149113876
Cited by
33
References
6
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 1 · 2013: 7 · 2012: 4
FWCI
2.62
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Donald W. Reynolds Foundation
  • Alzheimer's Association
  • Windgate Foundation
  • National Institutes of Health (AG19606, AG12411)
  • National Institute on Aging (AG 12411, R21AG033215, AG 17498, P30AG019606, P01AG012411, R01AG017498, AG033215, AG-19606)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD037989, HD 37989)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
apolipoprotein E, IL-1β, Alzheimer's disease, amyloid precursor protein, amyloid-beta, glutamate excitotoxicity, neuroinflammation, MAPK signaling, ERK, JNK, p38 MAPK, APOE ε4, glial activation, inflammatory cytokines, MAPK inhibitors
MeSH terms
Animals, Apolipoproteins E, Fluorescent Antibody Technique, Gene Expression Regulation, Inflammation, Male, Blotting, Western, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Glutamic Acid, Reverse Transcriptase Polymerase Chain Reaction, Rats, Interleukin-1beta, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review